Evoke Pharma, Inc.
EVOK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,352 | -$7,792 | -$8,224 | -$8,538 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $773 | $0 | $1,459 | $1,879 |
| Change in WC | -$1,398 | $1,550 | $132 | -$5,619 |
| Other Non-Cash | $518 | $1,257 | $37 | -$75 |
| Operating Cash Flow | -$5,459 | -$4,985 | -$6,596 | -$12,353 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6,718 | -$119 | $0 | $14,695 |
| Stock Repurch. | -$0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7,598 | $0 | $7,295 | -$1,266 |
| Financing Cash Flow | $14,316 | -$119 | $7,295 | $13,429 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8,857 | -$5,104 | $699 | $1,076 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,739 | $9,844 | $9,145 | $8,069 |
| End Cash | $13,597 | $4,739 | $9,844 | $9,145 |
| Free Cash Flow | -$5,459 | -$4,985 | -$6,596 | -$12,353 |